Home > Insider Trading > Filing (0000899243-21-005693)

Filing Details

Accession Number:: 0000899243-21-005693
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-10 16:53:27
Reporting Period:: 2021-02-08

Accepted Time:: 2021-02-10 16:53:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1756262	Transmedics Group Inc.	TMDX	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1112443	Abrams Capital, Llc	222 Berkeley Street, 21St Floor Boston MA 02116	No	No	Yes	No
1165407	Abrams Capital Management, Llc	222 Berkeley Street, 21St Floor Boston MA 02116	No	No	Yes	No
1292250	C David Abrams	222 Berkeley Street, 21St Floor Boston MA 02116	No	No	Yes	No
1292420	Abrams Capital Partners Ii, L.p.	222 Berkeley Street, 21St Floor Boston MA 02116	No	No	Yes	No
1358706	Abrams Capital Management, L.p.	222 Berkeley Street, 21St Floor Boston MA 02116	No	No	Yes	No
1525135	Riva Capital Partners Iii, L.p.	222 Berkeley Street, 21St Floor Boston MA 02116	No	No	Yes	No
1775371	Riva Capital Management Iii, Llc	222 Berkeley Street, 21St Floor Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-02-08	88,483	$26.24	3,411,376	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2021-02-09	786,664	$33.32	2,624,712	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes

Footnotes

Represents the weighted average sale price of shares sold in a series of open market transactions on the transaction date at prices ranging from $26.23646 to $26.2918 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Shares reported herein as beneficially owned by (i) Abrams Capital, LLC ("Abrams Capital") represent shares held for the account of Abrams Capital Partners II, L.P. ("ACP II") and other private investment funds for which Abrams Capital serves as general partner; and (ii) Riva Capital Management III, LLC ("RCM III") represent shares held for the account of Riva Capital Partners III, L.P. ("Riva III"), for which RCM III serves as general partner. Shares reported herein for Abrams Capital Management, L.P. (the "LP") and Abrams Capital Management, LLC (the "LLC") represent shares beneficially owned by private investment funds for which the LP serves as investment manager, including ACP II and Riva III. The LLC is the general partner of the LP. Shares reported herein for Mr. Abrams represent the above referenced shares reported for Abrams Capital, RCM III and the LLC. Mr. Abrams is the managing member of Abrams Capital, RCM III, and the LLC.
Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest in such shares, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
Of the shares sold on February 8, 2021, 41,063 shares were held for the account of ACP II; 36,868 shares were held for the account of Riva III; RCM III may be deemed to beneficially own 36,868 shares; Abrams Capital may be deemed to beneficially own 48,595 shares; and all such shares may be deemed to have been beneficially owned by Mr. Abrams, the LP and the LLC.
Represents the weighted average sale price of shares sold in a series of open market transactions on the transaction date at prices ranging from $33.04461 to $33.31643 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Of the shares sold on February 9, 2021, 365,078 shares were held for the account of ACP II; 327,777 shares were held for the account of Riva III; RCM III may be deemed to beneficially own 327,777 shares; Abrams Capital may be deemed to beneficially own 432,043 shares; and all such shares may be deemed to have been beneficially owned by Mr. Abrams, the LP and the LLC.